Screener / SEC EDGAR /CIK 0001582313 /10-K filed Feb 26, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Xenon Pharmaceuticals Inc. XENE

Compare with peers Embed
Insider trades since May 20, 2026

Insiders bought $1.7M and sold $1.2M on the market

Form 4
Bought on the market $1.7M 2 trades by 2 insiders
Sold on the market $1.2M 5 trades by 4 insiders
Sold under a 10b5-1 plan 47% of the value sold, under a plan set up in advance
Traded the most Ian Mortimer $1.1M PRESIDENT & CEO

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$1.7M bought on 1 day, $1.2M sold on 3 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Ian Mortimer
PRESIDENT & CEO, Director
$1.1M- Sep 30, 2026
Steven Gannon
Director
-$641K Aug 11, 2026
Thomas Patrick Kelly
Chief Financial Officer
$560K- Sep 30, 2026
Christopher John Kenney
Chief Medical Officer
-$426K Aug 28, 2026
Gary Patou
Director
-$70K Jun 5, 2026
Gillian Cannon
Director
-$63K Jun 5, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 5 open-market sales by officers and directors, 0 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Of 2 buys, 0. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Sep 30, 2026 Ian Mortimer Buy 30,000 1.1M
Sep 30, 2026 Thomas Patrick Kelly Buy 15,000 560K
Aug 28, 2026 Christopher John Kenney Sale (10b5-1) -6,368 383K
Aug 28, 2026 Christopher John Kenney Sale (10b5-1) -700 43K
Aug 11, 2026 Steven Gannon Sale -10,000 641K
Jun 5, 2026 Gillian Cannon Sale (10b5-1) -1,190 63K
Jun 5, 2026 Gary Patou Sale (10b5-1) -1,322 70K

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/XENE/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.